Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

  1. González, S.
  2. Scorticati, C.
  3. García-Arencibia, M.
  4. De Miguel, R.
  5. Ramos, J.A.
  6. Fernández-Ruiz, J.
Aldizkaria:
Brain Research

ISSN: 0006-8993

Argitalpen urtea: 2006

Alea: 1073-1074

Zenbakia: 1

Orrialdeak: 209-219

Mota: Artikulua

DOI: 10.1016/J.BRAINRES.2005.12.014 GOOGLE SCHOLAR